申请人:Castelhano Arlindo L.
公开号:US20090192177A1
公开(公告)日:2009-07-30
This invention pertains to compounds which specifically inhibit the adenosine A
1
and A
3
receptors and the use of these compounds to treat a disease associated with A
3
adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.
本发明涉及特异性抑制腺苷A1和A3受体的化合物,以及使用这些化合物治疗与A3腺苷受体相关的疾病的方法,包括向患者施用治疗有效量的化合物。